EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis

Nathan K P Wong, Emma L Solly iD, Richard Le iD, Victoria A Nankivell, Jocelyne Mulangala, Peter J Psaltis, Stephen J Nicholls, Martin K C Ng, Christina A Bursill iD, Joanne T M Tan iD

International Journal of Molecular Sciences · 15.03.2024 · 25 (6) · 3343

DOI: 10.3390/ijms25063343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.03.2024. Verfasst von Nathan K P Wong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia. Hauptthemen laut MEDLINE: Angiogenesis, Endothelial Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Foundation of Australia, National Health and Medical Research Council, Lin Huddleston Heart Foundation Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis is a critical physiological response to ischemia but becomes pathological when dysregulated and driven excessively by inflammation. We recently identified a novel angiogenic role for tripartite-motif-containing protein 2 (TRIM2) whereby lentiviral shRNA-mediated TRIM2 knockdown impaired endothelial angiogenic functions in vitro. This study sought to determine whether these effects could be translated in vivo and to determine the molecular mechanisms involved. CRISPR/Cas9-generated Trim2−/− mice that underwent a periarterial collar model of inflammation-induced angiogenesis exhibited significantly less adventitial macrophage infiltration relative to wildtype (WT) littermates, concomitant with decreased mRNA expression of macrophage marker Cd68 and reduced adventitial proliferating neovessels. Mechanistically, TRIM2 knockdown in endothelial cells in vitro attenuated inflammation-driven induction of critical angiogenic mediators, including nuclear HIF-1α, and curbed the phosphorylation of downstream effector eNOS. Conversely, in a hindlimb ischemia model of hypoxia-mediated angiogenesis, there were no differences in blood flow reperfusion to the ischemic hindlimbs of Trim2−/− and WT mice despite a decrease in proliferating neovessels and arterioles. TRIM2 knockdown in vitro attenuated hypoxia-driven induction of nuclear HIF-1α but had no further downstream effects on other angiogenic proteins. Our study has implications for understanding the role of TRIM2 in the regulation of angiogenesis in both pathophysiological contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AngiogenesisEndothelial CellsAnimalsMiceHindlimbHypoxiaHypoxia-Inducible Factor 1, alpha SubunitInflammationIschemiaNeovascularization, PathologicNeovascularization, PhysiologicUbiquitin-Protein LigasesTripartite Motif Proteins

Stichwörter der Autor:innen

HIF-1αeNOSinflammationischemianeovascularization

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitTrim2 protein, mouseUbiquitin-Protein LigasesTripartite Motif Proteins

Autor:innen und Institutionen

  • Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.
  • Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.
  • Department of Cardiology, St. Vincent's Hospital, Darlinghurst, NSW 2010, Australia.
  • Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
  • College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia.
  • Heart Foundation, Brisbane, QLD 4000, Australia.

ORCID-Profile: Emma L Solly, Richard Le, Christina A Bursill, Joanne T M Tan

Förderung

  • National Heart Foundation of Australia
  • National Health and Medical Research Council
  • Lin Huddleston Heart Foundation Fellowship
  • National Health and Medical Research Council of Australia

Zitieren

APA

Wong, N. K. P., Solly, E. L., Le, R., Nankivell, V. A., Mulangala, J., Psaltis, P. J., Nicholls, S. J., Ng, M. K. C., Bursill, C. A., & Tan, J. T. M. (2024). TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis. International Journal of Molecular Sciences, 25(6), 3343. https://doi.org/10.3390/ijms25063343

Vancouver

Wong NKP, Solly EL, Le R, Nankivell VA, Mulangala J, Psaltis PJ, et al. TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis. International Journal of Molecular Sciences. 2024;25(6):3343. doi:10.3390/ijms25063343

BibTeX
@article{Wong2024,
  author = {Wong, Nathan K P and Solly, Emma L and Le, Richard and Nankivell, Victoria A and Mulangala, Jocelyne and Psaltis, Peter J and Nicholls, Stephen J and Ng, Martin K C and Bursill, Christina A and Tan, Joanne T M},
  title = {TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {6},
  pages = {3343},
  doi = {10.3390/ijms25063343}
}
Kostenlos starten →